PTCT
PTC Therapeutics Inc
Price:  
25.94 
USD
Volume:  
649,185.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT Intrinsic Value

-1,113.00 %
Upside

As of 2024-02-22, the Intrinsic Value of PTC Therapeutics Inc (PTCT) is (262.77) USD. This PTCT valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 25.94 USD, the upside of PTC Therapeutics Inc is -1,113.00%.

The range of the Intrinsic Value is (588.07) - (176.60) USD

Note: result may not be accurate due to the invalid valuation result of DCF model.

25.94 USD
Stock Price
(262.77) USD
Intrinsic Value
Intrinsic Value Details

PTCT Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (588.07) - (176.60) (262.77) -1113.0%
DCF (Growth 10y) (226.94) - (736.28) (334.37) -1389.0%
DCF (EBITDA 5y) (145.23) - (212.55) (1,234.50) -123450.0%
DCF (EBITDA 10y) (196.42) - (299.58) (1,234.50) -123450.0%
Fair Value -42.53 - -42.53 -42.53 -263.94%
P/E (188.47) - (185.24) (201.15) -875.4%
EV/EBITDA (49.42) - (53.76) (48.22) -285.9%
EPV (53.74) - (70.26) (62.00) -339.0%
DDM - Stable (67.94) - (206.41) (137.18) -628.8%
DDM - Multi (108.41) - (258.97) (153.18) -690.5%

PTCT Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 1,957.43
Beta 1.40
Outstanding shares (mil) 75.46
Enterprise Value (mil) 3,148.53
Market risk premium 4.60%
Cost of Equity 10.24%
Cost of Debt 5.50%
WACC 8.25%